glutathione in breast milk maternal intake copper Frontiers Exploring the far-reaching consequences of

Common side effects are mild: Injection site irritation Mild headache Transient flushing Slight appetite changes Serious adverse effects are uncommon with appropriate dosing and medical supervision

Summary: In Phase 2 clinical trials, retatrutide was typically initiated at 2 mg once weekly via subcutaneous injection, with gradual dose escalation over several months under close medical supervision

This suggests AHK-Cu primarily protects existing DPCs from death rather than simply making them multiply faster an important distinction for treating hair loss where follicle miniaturisation involves progressive cell loss

After reconstitution, refrigerate at 2-8C and use within 30 days